Stocktoria

Viatris Inc VTRS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1973-02-01 · LEI

Viatris Inc statistics & valuation

Market cap$18.7B
P / S1.3×
P / B1.3×
P / FCF9.6×
FCF margin13.5%
Net debt$11.2B
Net debt / EBITDA82.5×
Enterprise value USD$29.8B
Earnings yield EBIT/EV-8.9%
Return on capital-8.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
33.90% 31.80% 31.20% 40.00% 41.70% 38.20% 35.10% 2019202020212022202320242025
Operating margin (%)
6.20% -1.80% -0.20% 9.90% 5.00% 0.10% -18.60% 2019202020212022202320242025
Return on equity (%)
2019202020212022202320242025
Shares outstanding
1.16B 1.35B 1.21B 1.22B 1.21B 2019202020212022202320242025
Net debt ($)
$10.74B $21.58B $19.02B $16.76B $15.20B $13.30B $11.16B 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
2019202020212022202320242025
Free cash flow margin (%)
13.80% 8.30% 14.30% 15.90% 16.40% 13.40% 13.50% 2019202020212022202320242025
Debt / equity (×)
0.94× 0.98× 0.96× 0.85× 0.79× 0.75× 0.85× 2019202020212022202320242025
EPS ($)
$0.01 -$0.49 -$1.05 $1.71 $0.05 -$0.53 -$3.00 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin35.1%38.2%41.7%40.0%31.2%31.8%33.9%
Operating margin-18.6%0.1%5.0%9.9%-0.2%-1.8%6.2%
FCF margin13.5%13.4%16.4%15.9%14.3%8.3%13.8%
Debt / equity0.85×0.75×0.79×0.85×0.96×0.98×0.94×
Current ratio1.381.651.671.581.101.221.21

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.